Publication shows utility of GMO in solid tumor research with study on detection of complex genomic rearrangements in prostate cancer
Bionano Genomics SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study using optical genome mapping (OGM) to detect structural variants (SV ) and balanced rearrangements relevant to the pathogenesis of prostate cancer (PCa). GMOs identified VS in all samples, potentially improving the success rate …